Waters Corporation EPS Growth (diluted)

EPS Growth (diluted) of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (diluted) growth rates and interactive chart. Year over year growth in diluted earnings per share.

Highlights and Quick Summary

  • EPS Growth (diluted) for the quarter ending December 30, 2020 was 11.86% (a -714.51% decrease compared to previous quarter)
  • Year-over-year quarterly EPS Growth (diluted) decreased by -127.55%
  • Annual EPS Growth (diluted) for 2020 was -3.8% (a -127.96% decrease from previous year)
  • Annual EPS Growth (diluted) for 2019 was 13.59% (a -99.54% decrease from previous year)
  • Annual EPS Growth (diluted) for 2018 was 2960.0% (a -3180.12% decrease from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (diluted) of Waters Corporation

Most recent EPS Growth (diluted)of WAT including historical data for past 10 years.

Interactive Chart of EPS Growth (diluted) of Waters Corporation

Waters Corporation EPS Growth (diluted) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 11.86% -1.93% -4.81% -43.05% -3.8%
2019 26.83% 13.11% 5.05% 7.86% 13.59%
2018 155.41% 8.28% 21.47% 6.87% 2960.0%
2017 -306.51% 10.46% 3.82% 13.91% -96.1%
2016 17.49% 9.29% 23.62% 0.0% 13.45%
2015 1.67% 4.48% 12.39% 40.24% 11.44%
2014 9.09% 17.54% 9.71% -41.01% -2.5%
2013 -17.5% 1.79% -5.5% 41.84% 0.19%
2012 32.45% 1.82% 1.87% -2.97% 10.66%
2011 11.03% 7.84% 18.89% 27.85% 15.52%
2010 25.93% 29.11% 25.0% 21.56%

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.